Cascadian Therapeutics Inc (CASC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-1999 | 12-1998 | 09-1998 | 06-1998 | 03-1998 | |
| Sales | 755 | 752 | 1,528 | 1,612 | 1,815 |
| Gross Profit | 750 | 752 | 1,528 | 1,612 | 1,815 |
| Operating Expenses | 4,530 | 0 | 0 | 0 | 0 |
| Operating Income | -3,775 | 752 | 1,528 | 1,612 | 1,815 |
| Other Income | -5 | 0 | 0 | 0 | 0 |
| Pre-tax Income | -3,780 | 752 | 1,528 | 1,612 | 1,815 |
| Net Income Continuous | -3,768 | -4,679 | -2,749 | -3,956 | -3,770 |
| Net Income Discontinuous | 0 | -113 | -808 | 0 | 0 |
| Net Income | $-3,768 | $-4,792 | $-3,557 | $-3,956 | $-3,770 |
| EPS Basic Total Ops | -3.24 | -3.60 | -2.88 | -3.24 | -3.24 |
| EPS Basic Continuous Ops | -3.07 | -3.80 | -2.20 | -3.24 | -3.06 |
| EPS Basic Discontinuous Ops | N/A | -0.09 | -0.65 | N/A | N/A |
| EPS Diluted Total Ops | -3.24 | -3.60 | -2.88 | -3.24 | -3.24 |
| EPS Diluted Continuous Ops | -3.07 | -3.80 | -2.20 | -3.24 | -3.06 |
| EPS Diluted Discontinuous Ops | N/A | -0.09 | -0.65 | N/A | N/A |
| EBITDA(a) | $-3,565 | $752 | $1,528 | $1,612 | $1,815 |